BAYN.DE - Bayer Aktiengesellschaft

XETRA - XETRA Precio retrasado. Divisa en EUR.

Bayer Aktiengesellschaft

Kaiser-Wilhelm-Allee 1
Leverkusen 51368
Germany
49 214 30 1
http://www.bayer.com

SectorHealthcare
IndustriaDrug Manufacturers—General
Empleados a tiempo completo98,737

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Werner BaumannChairman of Management & CEO4.66MN/D1962
Mr. Wolfgang U. NicklCFO & Member of Management Board1.9MN/D1969
Mr. Liam CondonMember of Management Board2.57MN/D1968
Mr. Heiko W. J. SchipperHead of Consumer Health Division & Member of Management Board2.35MN/D1969
Mr. Stefan OelrichPres of Pharmaceuticals Division & Member of the Board of Management2.81MN/D1968
Los importes son a partir de 31 de diciembre de 2019 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en EUR.

Descripción

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, cosmetics, and self-care solutions in the dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, cold and cough, foot care, and sun protection categories. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to veterinarians. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center at the University of Texas to develop cancer treatments; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies, supermarket and drugstore chains, online and other retailers, and hospitals, as well as directly to farmers. It has strategic research alliance with Kyoto University, Sensyne Health plc, and Atomwise Inc. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Gestión corporativa

La calificación ISS Governance QuickScore de Bayer Aktiengesellschaft a partir del 4 de diciembre de 2019 es 6. Las puntuaciones principales son Auditoría: 10; Junta: 5; Derechos del accionista: 1; Compensación: 4.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.